| | Should allosteric positive modulators of GABAA receptors be tested in the treatment of schizophrenia?Received 12 August 2004; accepted 16 August 2004. No abstract is available. To read the body of this article, please view the Full Text online. |
Department of Psychiatry, Psychiatric Institute, University of Illinois at Chicago, 1601 Taylor St, Chicago IL 60612 USA  Corresponding author.
PII: S0920-9964(04)00290-7 doi:10.1016/j.schres.2004.08.005 © 2004 Elsevier B.V. All rights reserved. | |
|
|
